Die aktuellsten Nachrichten von Arznei-News zu Diabetes finden Sie unter: News aus der Forschung zu Diabetes.
Liste
- Abasria
- AFREZZA
- Albiglutid
- Alogliptin
- Avandia
- Canagliflozin
- Dapagliflozin (Forxiga)
- Dasiglucagon
- Dulaglutid (Trulicity)
- Ebymect
- Edistride
- Efpeglenatid
- Empagliflozin (Jardiance)
- Eperzan
- Ertugliflozin
- Exenatid (Bydureon, Byetta)
- Fasiglifam
- Fiasp
- Finerenon
- Glibenclamid (Amglidia)
- Glyburid
- Glyxambi
- Imeglimin
- Incresync
- Insulin degludec
- Insulin Icodec
- Insulin lispro (Liumjev)
- Invokana
- Linagliptin (Trajenta)
- Liraglutid
- LixiLan
- Lixisenatid
- Lyxumia
- Metformin
- Nesina, Kazano und Oseni
- NovoMix
- Ogluo
- Pioglitazon (Actos)
- Pramlintid
- Qtern
- Qtrilmet
- Ranibizumab (Lucentis)
- Rapamycin
- Resveratrol
- Ryzodeq bei Diabetes
- Saxagliptin (Onglyza)
- Saxenda
- Segluromet
- Semaglutid (Ozempic)
- Semglee
- Sitagliptin (Januvia, Xelevia)
- Sotagliflozin
- Steglatro
- Steglujan
- Sulfonylharnstoff
- Suliqua
- Synjardy
- Teplizumab
- Tirzepatid
- Tofogliflozin
- Tolimidon
- TOTUM-63 (Valedia)
- Toujeo
- Tresiba
- Victoza
- Vildagliptin
- Vipdomet
- Vipidia
- Vokanamet
- Xigduo
- Xultophy